Comparing UroLift Experience Against Rezūm

Running, not enrolling · Not applicable

Conditions studied: Benign Prostatic Hyperplasia

In brief

C.L.E.A.R. Study is poised to compare the patient experience post procedure, including catheterization needs as well as retreatment and BPH medication rates following treatment with either the UroLift® System or Rezūm™ System through 12 months.

Key facts

Study ID
NCT04338776
Run by
NeoTract, Inc.
People needed
120
Starts
2021-01-22
Expected to finish
2025-12-01
Last updated by the study team
2025-10-14

Who can join

Age: 50 and older. Sex: male. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.